Ownership history in UBS Group AG · 10 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in REVELATION BIOSCIENCES INC (REVBW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1,133 | -167 | -12.8% | 0.00% | $12 | — |
| 2025 Q2 | ADDED | 1,300 | +1,028 | +377.9% | 0.00% | $16 | — |
| 2025 Q1 | REDUCED | 272 | -2,240 | -89.2% | 0.00% | $3 | — |
| 2024 Q4 | REDUCED | 2,512 | -156 | -5.8% | 0.00% | $18 | — |
| 2024 Q3 | REDUCED | 2,668 | -2,047 | -43.4% | 0.00% | $40 | — |
| 2024 Q2 | REDUCED | 4,715 | -73,285 | -94.0% | 0.00% | $94 | — |
| 2023 Q3 | ADDED | 78,000 | +71,911 | +1181.0% | 0.00% | $1K | — |
| 2023 Q1 | REDUCED | 6,089 | -12,666 | -67.5% | 0.00% | $97 | — |
| 2022 Q2 | ADDED | 18,755 | +12,336 | +192.2% | 0.00% | $2K | — |
| 2022 Q1 | INITIATED | 6,419 | — | — | 0.00% | $1K | — |
As of 2025 Q4 — sorted by position size